Pharmafile Logo
Pharmafocus logo
Advanced Search

RNA

Showing 13 posts of 13 posts found.

Beckman Coulter Life Sciences and Watchmaker Genomics enter collaboration

May 1, 2024
Manufacturing and Production Beckman Coulter Life Sciences, DNA, Pharmacy, RNA, Watchmaker Genomics, collaboration

Beckman Coulter Life Sciences and Watchmaker Genomics have announced that they have entered into a collaborative partnership with the aim …

News
dna-1903319_960_720

Cartesian Therapeutics announces successful trial of RNA cell therapy in autoimmunity

June 23, 2023
Research and Development Cartesian Therapeutics, Neurology, RNA, autoimmune, neurology

Clinical stage biotechnology company, Cartesian Therapeutics, has announced results from its clinical trial using RNA CAR T (rCAR T) therapy …

News
xxx

RNA breakthrough: Fluorescence used to track molecule movement

June 30, 2021
Research and Development AstraZeneca, RNA, mrna

Researchers at Chalmers University of Technology in Sweden have announced a breakthrough in the labelling method of messenger RNA (mRNA) …

News
andrei_r_-_shutterstock_1935537274_720

Quantoom & eTheRNA to collaborate on revolutionary RNA production system

June 29, 2021
Manufacturing and Production RNA, collaboration

Quantoom and eTheRNA immunotherapies have announced a strategic collaboration to develop a revolutionary RNA production system (RPS) for both research …

News

Doctors treat porphyria using innovative gene silencing drug

April 15, 2019
Sales and Marketing RNA, gene silencing, genetics, givosiran, health, porphyria

Doctors have successfully treated porphyria using an innovative ‘gene-silencing’ drug. Speaking to the BBC, Professor David Rees, from King’s College …

News
5204602349_c87b204860_z

FDA approves RNA therapy for rare genetic disease

August 13, 2018
Sales and Marketing FDA, Onpattro, Orphan Drugs, RNA, rare diseases

The US Food and Drug Administration has approved the RNA-based therapy Onpattro, for the treatment of the rare genetic disease …

News
Janssen image

Isis and J&J sign RNA deal

January 8, 2015
Research and Development, Sales and Marketing Isis, J&J, JJ, Janssen, RNA, gastrointestinal tract

Isis Pharmaceuticals is collaborating with Johnson & Johnson’s pharma unit Janssen to develop antisense drugs to treat autoimmune disorders. The …

News

Gene silencing back on the books for Roche

August 5, 2014
Research and Development, Sales and Marketing RNA, Roche, Santaris, gene silencing

Roche will pay $450 million to acquire the RNA specialist firm Santaris Pharma in order to once again begin research …

News
Sanofi image

Sanofi signs new genetics deal with Isarna

January 14, 2014
Manufacturing and Production, Research and Development, Sales and Marketing DNA, RNA, Sanofi, aso, isarna

Sanofi has agreed to produce genetic compounds developed by German biotech Isarna Therepeutics to accelerate their progress to the clinical …

News
The RNAi therapeutic mechnism

New frontiers in drug discovery

September 11, 2012
Business Services, Manufacturing and Production, Research and Development, Sales and Marketing RNA, drug discovery, therapeutic

Despite the success of small molecule and biologic drugs such as monoclonal antibodies, there remain many areas of unmet medical …

Feature

AstraZeneca extends siRNA collaboration

July 14, 2010
Research and Development AstraZeneca, RNA, Silence Therapeutics

AstraZeneca has agreed a one-year extension on its siRNA development collaboration with London-based Silence Therapeutics. Silence is a specialist in …

News

Sanofi signs microRNA therapy deal

June 23, 2010
Research and Development RNA, Regulus, Sanofi-Aventis

Sanofi-Aventis has entered into a global strategic alliance with US-based therapeutics firm Regulus to develop and commercialise microRNA therapeutics. Regulus …

News

GSK signs RNA therapeutics alliance

March 31, 2010
Research and Development GlaxoSmithKline, Isis, RNA

GlaxoSmithKline has forged a new strategic alliance with Isis Pharmaceuticals to exploit the specialist company’s expertise in anti-RNA therapeutics. California-based …

News

Latest content

FDA approves AbbVie’s Skyrizi for UC treatment

June 20, 2024

Takeda shares data from phase 3 trial of CIPD treatment

June 20, 2024

EC grants marketing authorisation to Sobi’s Altuvoct for haemophilia A treatment

June 19, 2024

First patient dosed in Assembly Biosciences’ phase 1b trial for hepatitis B treatment

June 19, 2024

FDA approves Merck’s Capvaxive for prevention of pneumococcal disease

June 18, 2024